Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Urtica dioica agglutinin (UDA) as a potential candidate for inhibition of SARS-CoV-2 Omicron variants: In silico prediction and experimental validation.

Phytomedicine : international journal of phytotherapy and phytopharmacology - 1 Mar 2023

Sabzian-Molaei Fatemeh, Hosseini Seyedrafi, Alipour Atefeh, Ghaderi Hajarossadat, Fotouhi-Chahouki Fatemeh, Hadi Amin, Shahsavarani Hosein

Abstract excerpt

BACKGROUND: The high number of mutations and consequent structure modifications in a Receptor-Binding Domain (RBD) of the spike protein of the Omicron variant of SARS-CoV-2 increased concerns about evading neutralization by antibodies induced by previous infection or vaccination. Thus, developing novel drugs with potent inhibitory activity can be considered an alternative for treating this highly transmissible...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19
Share to Molecular Dynamics Simulation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Protein Binding

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 36681052
DOI: 10.1016/j.phymed.2023.154648
PMCID: PMC9815882

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Urtica dioica agglutinin (UDA) as a potential candidate for inhibition of SARS-CoV-2 Omicron variants: In silico prediction and experimental validation.PMID 36681052Read ↗

In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein Trimer.Semantic proximity Read ↗

In Silico Study of Coumarins: Wedelolactone as a Potential Inhibitor of the Spike Protein of the SARS-CoV-2 VariantsSemantic proximity Read ↗

Daucosterol and Beta-Sitosterol – the Future-Ready phytochemicals from Terminalia chebula to combat SARS-CoV-2Semantic proximity Read ↗

Coronil biochemically inhibits the interaction of various clinically relevant mutants of SARS-CoV-2 Spike Proteins (Omicron Variants) with human ACE2 receptorSemantic proximity Read ↗

Computational studies on the interaction of SARS-CoV-2 Omicron SGp RBD with human receptor ACE2, limonin and glycyrrhizic acid.Semantic proximity Read ↗

Artemisia argyi potentially prevents the infections with SARS-CoV-2 variantsSemantic proximity Read ↗

In-Silico Investigation of Inhibiting Property of Phytoconstituents of Medicinal Herb ‘Aconitum Heterophyllum’ Against Omicron Variant of SARS-CoV-2Semantic proximity Read ↗

Inhibiting Property of Phytoconstituents of ‘Aconitum Heterophyllum’ Against Omicron Variant of SARS-CoV-2: Molecular Docking, Molecular Dynamic and MM-GBSA approachSemantic proximity Read ↗

Identification of novel inhibitors of Angiotensin-converting enzyme 2 (ACE-2) receptor from Urtica dioica to combat coronavirus disease 2019 (COVID-19)Semantic proximity Read ↗

Predictive Insights Into Bioactive Compounds from Streptomyces as Inhibitors of SARS-CoV-2 Mutant Strains by Receptor Binding Domain: Molecular Docking and Dynamics Simulation ApproachesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.